[Remote] Senior Director, Senior Corporate Counsel at Axsome Therapeutics Inc

Remote

Apply Now

Not SpecifiedCompensation

N/AExperience Level

N/AJob Type

Not SpecifiedVisa

N/AIndustries

Requirements

Master of Laws (LL.M.) degree from an accredited law school
At least 8 years of experience in a law firm and/or in-house legal department in the life sciences industry (biotechnology, pharmaceuticals, medical device, healthcare or related fields)
Contract drafting and negotiation experience, particularly in Clinical Trial Agreements (CTA)
Self-motivated, innovative, strategic, detail-oriented, and able to consistently provide high-quality and timely work product
Excellent communication and interpersonal skills

Responsibilities

Lead the negotiating and drafting of various business contracts, including vendor agreements, IT/software licensing, data privacy agreements, service agreements, clinical trial agreements, confidentiality agreements, consulting agreements, material transfer agreements
Provide high-quality, timely, and practical legal advice and guidance on regulatory, research and development, IT, and clinical activities
Foster and develop strong relationships with internal company stakeholders in legal, clinical operations, research and development, IT, outsourcing, and quality
Support the review and negotiation of IT-related agreements, including SaaS contracts, data processing agreements, cybersecurity policies
Identify legal risks related to business operations and develop strategies to mitigate exposure while supporting business objectives
Create, support, and update library of template contracts, policies, and playbooks
Assist in the creation and implementation of company policies related to business operations and legal risk management
Develop training materials on contracting topics for Vera employees and conduct associated company trainings
Contribute to legal due diligence activities arising from contract reviews
Work cross-functionally with Clinical, Compliance, HR, IT, Finance, and Operations teams to align legal strategies with business goals

Skills

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters

2012Year Founded

$430.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Performance Bonus

Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.

Potential delays in AXS-07 launch amid growing market anticipation.

Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.

AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.

Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.

Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.

Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI

Try Jobo Free